Frühauf Nils R, Malagó Massimo, Frilling Andrea, Beckebaum Susanne, Broelsch Christoph E
Department of General Surgery and Transplantation, University Essen, Essen, Germany.
Surg Technol Int. 2004;13:183-9.
Currently, orthotopic liver transplantation (LT) represents the treatment of choice for most end-stage liver diseases. Advances in surgical techniques and immunosuppressive therapy have markedly increased its success. However, the main obstacle in LT remains the lack of donor organs with a current mortality rate for patients on the waiting list of up to 20%. This chapter focuses on developments in SLT techniques and living-donor LT to alleviate this problem. SLT yields a net gain of organs, in that it uses one organ to save either an adult and a child, or two adults. The initially used technique of ex-situ splitting is being replaced progressively by the in-situ splitting technique, which yields better preserved grafts. The latest step has been the introduction of living-donor segmental LT. The systematic combination of both techniques may lead to a further reduction of mortality for patients on the waiting list for LT.
目前,原位肝移植(LT)是大多数终末期肝病的首选治疗方法。手术技术和免疫抑制疗法的进步显著提高了其成功率。然而,肝移植的主要障碍仍然是供体器官短缺,目前等待名单上患者的死亡率高达20%。本章重点介绍减体积肝移植技术和活体供肝肝移植的进展,以缓解这一问题。减体积肝移植可实现器官净增加,因为它能用一个器官挽救一名成人和一名儿童或两名成人。最初使用的异位分割技术正逐渐被原位分割技术所取代,原位分割技术能使移植肝保存得更好。最新进展是引入了活体供肝节段性肝移植。这两种技术的系统结合可能会进一步降低肝移植等待名单上患者的死亡率。